← Russell 3000 cross-section

TDOC Teladoc Health, Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-07-30, not restated
Healthcare

Scale

Market cap
$1.2bn
Revenue TTM
$2.5bn
Net income TTM
$-177m
Free cash flow
$254m
Composite score
72.9
Sector rank
#1941

Valuation

P / E
EV / EBITDA
EV / sales
0.2
FCF yield
21.92%
Earnings yield vs 10-yr
-20.06pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-7.1%
EBITDA margin
ROE
-13.5%
ROIC
-34.9%
Revenue growth
-2.1%

Insider activity, last 90 days

Net open-market
$-0.63m
Buyers
0
Sellers
6

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

The following table presents revenues disaggregated by revenue source and geography for the three months ended June 30, 2026 and 2025: The following table presents revenues disaggregated by revenue source and geography for the six months ended June 30, 2026 and 2025: Total revenue was $606.9 million for the three months ended June 30, 2026, compared to $631.9 million for the three months ended June 30, 2025, a decrease of $25.0 million, or 4%. …Teladoc Health, Inc., 10-Q, period ended 2026-06-30, filed 2026-07-30

Read the full passage →